1. Introduction
Periodontitis is a microbially driven host-mediated disease that leads to loss of periodontal attachment and bone [1] At first stage, gingival inflammation (gingivitis) is caused by bacterial biofilm formation. Consequently, progression of periodontal disease to destructive periodontitis depends on microbial dysbiosis in response to nutrients from gingival inflammatory and tissue breakdown products favouring the growth of some bacterial species, and also in response to anti-bacterial mechanisms that try to contain the microbial challenge within the gingival sulcus [1]. According to the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions, severity and complexity of periodontitis are assessed following a staging process (Stage I, II, III and IV) that consider the initial clinical attachment level (CAL) whereas, the direct or indirect rate of progression is based on a grading scale (Grade A, B and C) that involves radiographic bone loss (RBL) and presence of risk factors such as smoking and diabetes [1].
However, periodontal inflammation is not just a local phenomenon. The possible link between periodontitis and systemic conditions has been extensively reported in 2013 in the Proceedings of a Workshop jointly held by the European Federation of Periodontology and the American Academy of Periodontology, where authors agreed that pro-inflammatory (infectious) events related to periodontitis may have a systemic impact and, vice-versa, some systemic disorders may influence periodontal outcomes [2,3,4].
Several studies have reported that both acute local and systemic inflammatory response is increased up to 24–48 h after periodontal treatment, either surgical or non-surgical [5,6]. Since this might be additional to the pre-existing inflammatory burden of patients with compromised medical history and/or uncontrolled systemic diseases, some have tried to investigate how to manage and modulate the impact of periodontal treatment on systemic inflammation.
Therefore, the present narrative review focuses on describing the existing evidence on (i) the impact of periodontitis and periodontal treatment on systemic health and (ii) effective measures to modulate the effect of periodontal treatment on systemic inflammation. Furthermore, the link between periodontitis and systemic diseases, the impact of periodontitis on the quality of life and public health and the effects of periodontal treatment on other co-morbidities will be covered in this article.
CC BY 4.0. "Managing the Systemic Impact of Periodontitis" by Mainas G, Ide M, Rizzo M et al., Medicina (Kaunas, Lithuania) (2022). https://doi.org/10.3390/medicina58050621. Licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Peer-reviewed and open access; full text from PubMed Central (PMC9147054). Headings and layout adapted for reading; figures and tables are in the original.